Clinical Trial Phases Explained: Phase 1 to Approval
Clinical trial phases explained: what happens in Phase 1, 2, 3 and 4, how each stage is designed, and how trial evidence supports FDA and EMA approval.
Clinical development is the trial programme a candidate medicine passes through: first-in-human safety studies, then dose-finding, then the larger comparisons against existing treatment or placebo that a regulator will read.
We report on how these programmes are designed, what their endpoints actually measure, and the difference between a trial that shows a treatment works and one that shows it works better than what patients already have.
Clinical trial phases explained: what happens in Phase 1, 2, 3 and 4, how each stage is designed, and how trial evidence supports FDA and EMA approval.
The drug development process from laboratory research to patients: translational research, decision gates, who does what, and how a medicine reaches clinical use.
Clinical trial phases in drug development: what evidence each phase produces, how go/no-go decisions are made, and how phases differ for biologics and vaccines.